B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin α2β1-mediated FAK and AKT activation (vol 5, 100903, 2023)

被引:0
|
作者
Tang, Yao [1 ,2 ]
Xu, Zhijie [1 ,2 ]
Xu, Fuyuan [1 ,2 ]
Ye, Juan [1 ,2 ]
Chen, Jianxu [1 ,2 ]
He, Jianzhong [4 ]
Chen, Yingchun [1 ]
Qi, Chunhui [1 ,2 ]
Huang, Hongbin [1 ,2 ]
Liu, Ruiyang [1 ,2 ]
Shan, Hong [1 ,3 ]
Xiao, Fei [1 ,2 ,5 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 5, Guangdong Prov Engn Res Ctr Mol Imaging, 2 Mei Hua East Rd, Zhuhai 519000, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Infect Dis, Zhuhai 519000, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 5, Ctr Intervent Med, Zhuhai 519000, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Pathol, Zhuhai 519000, Guangdong, Peoples R China
[5] First Peoples Hosp Kashi, Kashi Guangdong Inst Sci & Technol, Kashi 844000, Xinjiang, Peoples R China
关键词
D O I
10.1016/j.jhepr.2024.101042
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin a2b1-mediated FAK and AKT activation
    Tang, Yao
    Xu, Zhijie
    Xu, Fuyuan
    Ye, Juan
    Chen, Jianxu
    He, Jianzhong
    Chen, Yingchun
    Qi, Chunhui
    Huang, Hongbin
    Liu, Ruiyang
    Shan, Hong
    Xiao, Fei
    JHEP REPORTS, 2023, 5 (12)
  • [2] Glycosyltransferase B4GALNT1 promotes immunosuppression in hepatocellular carcinoma via the HES4-SPP1-TAM/Th2 axis
    Wang, Zhifeng
    Liu, Jiaxin
    Wang, Xiaoming
    Wu, Qingyun
    Peng, Qiao
    Yang, Tianxiao
    Sun, Xuehui
    Wang, Xiaofeng
    Wang, Yilin
    Wu, Weicheng
    MOLECULAR BIOMEDICINE, 2024, 5 (01):
  • [3] 1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway
    Tian, Tao
    Li, Chun-Li
    Fu, Xiao
    Wang, Shu-Hong
    Lu, Jun
    Guo, Hui
    Yao, Yu
    Nan, Ke-Jun
    Yang, Yu-Juan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (04) : 1311 - 1325
  • [4] Derlin-1 Promotes the Progression of Human Hepatocellular Carcinoma via the Activation of AKT Pathway
    Fan, Jiye
    Tian, Liying
    Huang, Shuhong
    Zhang, Jing
    Zhao, Baohua
    ONCOTARGETS AND THERAPY, 2020, 13 : 5407 - 5417
  • [5] B4GALNT1 promotes carcinogenesis by regulating epithelial-mesenchymal transition in hepatocellular carcinoma based on pan-cancer analysis
    Liu, Wenli
    Chen, Yutong
    Yang, Jinqiang
    Guo, Mingliang
    Wang, Li
    JOURNAL OF GENE MEDICINE, 2023, 25 (11):
  • [6] Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1-Mediated Activation of NF-κB Signaling
    Guo, Xingxian
    Yang, Fan
    Liu, Tianyi
    Chen, Amei
    Liu, Dina
    Pu, Jiangxia
    Jia, Can
    Wu, Yuanhong
    Yuan, Junfeng
    Ouyang, Nan
    Herz, Joachim
    Ding, Yinyuan
    ADVANCED SCIENCE, 2024, 11 (45)
  • [7] BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway
    Qiu, Jiannan
    Zhang, Shaopeng
    Wang, Peng
    Wang, Hao
    Sha, Bowen
    Peng, Hao
    Ju, Zheng
    Rao, Jianhua
    Lu, Ling
    CANCER MEDICINE, 2020, 9 (21): : 8159 - 8172
  • [8] Phase separation of EEF1E1 promotes tumor stemness via PTEN/ AKT-mediated DNA repair in hepatocellular carcinoma
    Pu, Xiaofan
    Zhang, Chaolei
    Jin, Junbin
    Jin, Yifeng
    Ren, Jianghao
    Zhou, Senhao
    Patel, Harsh
    Chen, Jingyun
    Wu, Bicheng
    Chen, Leyi
    Qian, Haoran
    Lin, Tianyu
    CANCER LETTERS, 2025, 613
  • [9] FEN1 upregulation mediated by SUMO2 via antagonizing proteasomal degradation promotes hepatocellular carcinoma stemness
    Peng, Zhenxiang
    Wang, Shuling
    Wen, Diguang
    Mei, Zhechuan
    Zhang, Hao
    Liao, Shengtao
    Lv, Lin
    Li, Chuanfei
    TRANSLATIONAL ONCOLOGY, 2024, 44
  • [10] EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin α5β1-mediated YAP activation in Ewing sarcoma
    Shaohui He
    Quan Huang
    Jinbo Hu
    Lei Li
    Yanbin Xiao
    Hongyu Yu
    Zhitao Han
    Ting Wang
    Wang Zhou
    Haifeng Wei
    Jianru Xiao
    British Journal of Cancer, 2019, 121 : 922 - 933